PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

Crystalline DNA “Flowers” Created for Targeted Drug Delivery

They can unfold and fold up to ten times, enabling multiple uses.

American chemists have developed nanocrystals made from DNA strands and inorganic molecules that can repeatedly open and close in response to changes in environmental conditions — much like flowers do. This property allows the DNA “flowers” to be used for packaging and targeted drug delivery, the University of North Carolina at Chapel Hill (UNC) press office reported.

“No one would refuse the appearance of ‘smart capsules’ that automatically release medicine when a disease is detected and stop once the patient is cured. Our material makes this possible,” said Ronit Freeman, an associate professor at UNC, as quoted by the university’s press release. “These DNA ‘flowers’ can be designed to deliver precise doses of medication, perform biopsies, or even destroy blood clots.”

The “smart capsules” consist of DNA strands embedded within nanoscale crystals of cobalt pyrophosphate — an inorganic compound of cobalt, phosphorus, and oxygen. The researchers developed a method for “stitching together” different crystal blocks with DNA strands, allowing the creation of complex structures that respond to external stimuli.

In particular, the team designed structures resembling sea anemones and terrestrial flowers that can open and close in response to signals such as threats or changes in light intensity. For the DNA “flowers,” the trigger is a change in the acidity (pH) of the surrounding environment.

When the environment becomes more acidic, the DNA strands inside the “flower” fold into denser structures, causing the nanocapsule to close. When it returns to a neutral environment, the structure reopens, releasing its contents into the new medium or cell. This mechanism, researchers note, can be used to deliver drugs to specific tissues or organs, or to extract biomarkers indicating the development of diseases or tumors.

Experiments showed that the DNA “flowers” can fold and unfold about ten times, making them reusable for a wide range of applications. Beyond medicine, such structures could also be employed to mitigate the effects of technological or natural disasters, or to perform complex reaction chains in pharmaceutical and chemical industries — potentially simplifying and reducing the cost of production processes.

Source: TASS, October 20, 2025.

Current news

  • February 5, 2026

    Alikhanov: At Least 10 Pharmaceutical Manufacturing Facilities to Be Built in Russia by 2030

    By 2030, Russia plans to build at least 10 new pharmaceutical manufacturing facilities, Russian Minister…

  • February 5, 2026

    Ministry of Industry and Trade: The Share of Domestic Medicines in Russia Has Exceeded 60%

    The share of domestically produced medicines in Russia stands at 63%, and exceeds 80% in…

  • February 5, 2026

    Special Procedure for the Sale of Foreign Medicines Extended Until the End of 2027

    The special procedure for the sale in Russia of registered foreign medicinal products will remain…

  • February 5, 2026

    A Drug for Hepatitis B Therapy Developed in Russia

    Russian scientists have developed a drug for the treatment of hepatitis B based on CRISPR/Cas9…

  • February 5, 2026

    Methodological Guidelines Approved for Assessing Technological Processes in Pharmaceutical Manufacturing to Implement Government Resolution No. 719

    Starting July 1, 2026, Government Resolution of the Russian Federation No. 1392 dated September 10,…

LLC “BioJet”. all rights reserved

  • Legal information